Barinthus Biotherapeutics Cash Flow Statement (2020-2026) | BRNS

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-16.86M-5.53M-16.72M2.57M15.69M8.22M-21.16M-18.22M-23.82M-14.11M-17.29M-15.52M-16.94M-8.13M-20.59M-19.66M-21.13M-14.57M-11.10M-5.53M
Depreciation and Depletion (Quarter)
0.20M0.20M0.40M0.30M0.40M0.50M0.70M0.70M0.60M0.70M0.70M0.60M1.20M1.20M0.10M0.30M0.20M
Share-based Compensation (Quarter)
8.74M3.37M3.58M3.98M2.75M1.10M2.04M2.22M1.99M0.06M0.79M1.61M1.20M1.14M0.76M0.47M-0.28M-0.41M0.70M0.56M
Deferred Taxes (Quarter)
-0.01M-0.03M-0.06M-0.86M-0.92M-0.62M-1.93M-0.52M-1.14M-0.60M-0.82M-0.04M-0.01M-0.00M0.00M-0.02M-0.03M-0.07M-0.06M-0.02M
Gains from Sales and Divestitures (Quarter)
0.51M0.51M0.51M
Gains from Investment Securities (Quarter)
2.16M0.00M-0.01M0.63M0.32M-0.59M6.78M6.39M-0.03M0.06M0.31M0.00M0.30M0.05M-0.15M0.08M
Asset Writedowns and Impairment (Quarter)
5.26M4.67M1.13M
Non-cash Items (Quarter)
19.82M16.06M16.95M14.80M11.50M8.70M1.48M9.00M6.50M4.10M
Cash from Operations (Quarter)
-14.62M-2.02M-7.97M-6.58M-8.39M11.88M-11.34M-3.17M-16.96M-11.19M-19.60M-11.82M-12.01M-18.20M13.09M-14.90M-18.11M-10.73M-4.24M-3.37M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.10M0.09M0.32M0.97M0.99M1.19M1.18M1.22M1.30M1.47M1.44M1.43M1.47M1.48M1.43M2.03M2.00M0.90M0.91M0.86M
Change in Working Capital
Change in Receivables (Quarter)
-0.28M0.01M-0.07M18.35M-1.32M-10.87M-0.33M-4.96M-0.65M-0.19M
Change in Account Payables (Quarter)
-0.84M-1.87M-0.11M1.74M-0.96M-0.63M1.00M-1.71M-0.21M2.33M-3.79M-0.52M1.49M0.39M-0.46M-1.16M0.34M-1.04M-0.35M0.64M
Change in Accured Expenses (Quarter)
0.87M1.08M2.57M2.83M-3.32M5.55M-4.32M-1.31M1.59M4.96M-3.24M-0.82M1.96M-2.67M1.98M-2.52M-0.24M-0.57M-0.45M2.59M
Other Working Capital Changes (Quarter)
-0.42M0.78M-0.01M1.12M-0.95M-0.17M-5.25M4.80M-1.88M2.71M1.21M-5.69M-0.48M0.14M-0.16M-1.48M-1.05M
Investing Activities
Capital Expenditures (Quarter)
-0.06M0.71M0.42M1.09M2.05M-2.93M5.92M2.51M-2.00M5.06M-0.15M0.31M0.19M0.11M0.28M0.04M
Sales of Property, Plant and Equipment (Quarter)
0.37M0.05M0.06M
Cash from Investing Activities (Quarter)
-0.20M-0.13M-12.19M-1.09M-2.05M-2.02M-0.59M-2.51M-3.02M-0.04M0.15M-0.31M-0.19M-0.11M-0.28M-0.01M-0.03M0.45M0.00M0.06M
Financing Activities
Other financing activities (Quarter)
0.76M1.39M1.87M
Cash from Financing Activities (Quarter)
102.31M-1.39M0.01M-0.16M0.48M1.69M0.03M0.05M0.11M0.50M0.36M0.47M0.84M0.00M
Additional items
Exchange Rate Effect (Quarter)
0.20M-6.21M0.34M-5.63M2.18M-2.09M5.73M0.94M1.65M-1.54M1.12M-0.49M-0.36M6.17M-7.35M3.08M5.35M-1.83M0.42M-1.35M
Change in Cash (Quarter)
87.68M-9.75M-19.82M-13.46M-8.27M7.78M-5.72M-3.06M-18.30M-12.72M-18.22M-12.12M-12.20M-11.67M6.30M-11.82M-12.79M-12.11M-3.82M-4.66M
Free Cash Flow (Quarter)
-14.57M-2.73M-8.40M-7.67M-10.45M14.81M-17.26M-5.68M-14.96M-16.25M-19.45M-12.13M-12.20M-18.31M12.81M-14.90M-18.15M-10.73M-4.24M-3.37M
Net Cash Flow (Quarter)
87.48M-3.53M-20.15M-7.83M-10.45M9.87M-11.45M-3.99M-19.95M-11.18M-19.34M-11.63M-11.84M-17.85M13.64M-14.90M-18.14M-10.28M-4.24M-3.31M